Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early-Use Long Acting Tacrolimus in Lung Transplant Recipients
NCT04469842Phase 1Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Dec 2023
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tacrolimus + Wuzhi capsule in lung transplant rejection (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoint: Safety and Tolerability at 6 months. Started Dec 2023; status: recruiting.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
lung transplant rejection
Beyond the preview
Go deeper on NCT04469842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04469842.